Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TTI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAB28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDLIM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HCG18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ITPKB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LARP7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506558 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JMY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF259P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMBRD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STK11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITGB3BP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLAIN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBMX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ISCA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on